To Whom it may concern
December 19, 2023
Ohara Pharmaceutical Co., Ltd.

Announcement of Recapitalization of Africa Healthcare Network (AHN)-Expansion of healthcare infrastructure through the development of dialysis
services in sub-Saharan countries

Ohara Pharmaceutical Co., Ltd. (President and CEO: Seiji Ohara, hereinafterreferred to as 'the Company') has participated in the recapitalization plan ofAfrica Healthcare Network (CEO: Matt Williams, hereinafter referred to as'AHN'), which operates dialysis services in the African continent. The Company
is pleased to announce its participation in the capital increase plan.
Details
1. Recapitalization
The company has joined with Africa50, a company established by the African
Development Bank and funded by the governments of 29 African countries, andAfricInvest, an investment company that has been investing in the Africancompanies since the early 1990s, to participate in AHN's recapitalization plan.
AHN plans to use the funding to accelerate the roll-out of its dialysis clinics inAfrican countries and rapidly improve the standard of care through enhanced
services such as renal disease management and early diagnosis using
advanced technology and trained staff.
2. Background
The Company has been supporting the growth of local companies in thehealthcare sector in Africa, with the aim of contributing to the resolution of social

Ohara Pharmaceutical Co., Ltd.

issues through the spread of healthcare services and the improvement ofhealthcare standards.
When a patient suffers from kidney failure, it is not possible to recover the lost
kidney function without a kidney transplant, so the patient needs to go to a
medical institution for regular dialysis treatment. However, in African countries,
medical facilities providing dialysis treatment are concentrated in urban areas,
and there is an urgent need to promote an environment that facilitates access todialysis treatment and testing in unserved areas.
AHN is working to build a network of highly convenient dialysis clinics byreducing costs through its unique supply chain network and by developing
facilities that utilize available space in medical facilities, so that dialysis
treatment can be widely accessed by patients with kidney disease.
AHN plans to expand its dialysis clinics widely in Africa through thisrecapitalization, which is expected to make a significant contribution to thedevelopment of Africa's healthcare infrastructure. It is expected to make asignificant contribution to the development of Africa's healthcare infrastructure.
Africa Healthcare Network
Company name: Africa Healthcare Network
Location: Mauritius
Representative : Matt Williams
Established : 2015
URL : https://www.africahealthcarenetwork.com/
BUSINESS:
Africa Healthcare Network (AHN) provides advanced dialysis services andimproving the healthcare environment so that kidney disease patients in Africa
can access quality treatment, state-of-the-art facilities, and a compassionate
commitment to patients.
Ohara Pharmaceutical Co., Ltd.
Company name: Ohara Pharmaceutical Co., Ltd.
Location: Shiga, Japan

Ohara Pharmaceutical Co., Ltd.

Representative: Seiji Ohara
Establishment: 1964
URL: https://www.ohara-ch.co.jp/Business activities:
Core business of Ohara pharmaceutical Co., Ltd is the discovery andmanufacture of orphan and generic drugs. The company focuses on thedevelopment of orphan drugs with the areas of child cancer andhepatobiliary/pancreatic cancer, and focuses on the development, manufacture
and marketing of generic drugs that prevent medical accidents. We aim to be acompany that can provide Total Healthcare Solutions by utilizing innovation not
only in treatment, but also in prevention, diagnosis and aftercare.

Contact information
Ohara Pharmaceutical Co., Ltd.
Representatives: Iyo
TEL: 03-6740-7701
FAX: 03-6740-7702

Ohara Pharmaceutical Co., Ltd.